DS

Dale B. Schenk

EP Elan Pharmaceuticals: 4 patents #1 of 49Top 3%
Johnson & Johnson: 4 patents #45 of 830Top 6%
BH Brigham and Women's Hospital: 1 patents #10 of 52Top 20%
University of California: 1 patents #154 of 943Top 20%
UT University Of Tennessee: 1 patents #13 of 60Top 25%
📍 Campbell, CA: #5 of 304 inventorsTop 2%
🗺 California: #800 of 41,698 inventorsTop 2%
Overall (2011): #6,459 of 364,097Top 2%
8
Patents 2011

Issued Patents 2011

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
8034348 Prevention and treatment of amyloidogenic disease Nicki Vasquez, Theodore Yednock 2011-10-11
8034339 Prevention and treatment of amyloidogenic disease 2011-10-11
7993627 Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammal Martin Citron, Dennis J. Selkoe, Peter A. Seubert 2011-08-09
7977316 Prevention and treatment of amyloidogenic diseases 2011-07-12
7964192 Prevention and treatment of amyloidgenic disease 2011-06-21
7928203 Chimeric, humanized, or human antibody 2A4 Peter A. Seubert, Jonathan S. Wall, Jose Saldanha 2011-04-19
7919088 Treatment and delay of onset of synucleinopathic and amyloidogenic disease Kate Dora Games, Manuel J. Buttini, Tamie J. Chilcote, Edward Rockenstein, Eliezar Masliah 2011-04-05
7893214 Humanized antibodies that recognize beta amyloid peptide 2011-02-22